Alnylam Pharmaceuticals
ALNY
#792
Rank
NZ$55.63 B
Marketcap
NZ$415.81
Share price
3.86%
Change (1 day)
-49.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

ESG Reports

Thumbnail Alnylam Pharmaceuticals
 ESG Report 2025

ESG Report 2025

Language: English

View ESG Report
Thumbnail Alnylam Pharmaceuticals
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report